Wedbush Forecasts Higher Earnings for Neurocrine Biosciences
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities researchers at Wedbush raised their Q2 2025 earnings estimates for shares of Neurocrine Biosciences in a report issued on Tuesday, May 6th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of $1.12 for the quarter, up from their previous forecast […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities researchers at Wedbush raised their Q2 2025 earnings estimates for shares of Neurocrine Biosciences in a report issued on Tuesday, May 6th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of $1.12 for the quarter, up from their previous forecast […]
